Tipranavir: A Ritonavir-Boosted Protease Inhibitor

By Croom Katherine F.   Keam Susan J.  

Drugs, Vol. 65, Iss. 12, 2005-01 ,pp. : 1669-1677

Adis International

Access to resources Recommend Favorite

Tipranavir: A Ritonavir-Boosted Protease Inhibitor: A Viewpoint by Charles Hicks

By Hicks Charles  

Drugs, Vol. 65, Iss. 12, 2005-01 ,pp. : 1678-1679

Adis International

Access to resources Recommend Favorite

Comparison of the Pharmacokinetics of Apricitabine in the Presence and Absence of Ritonavir-Boosted Tipranavir: A Phase I, Open-Label, Controlled, Single-Centre Study

By Cox Susan  

Clinical Drug Investigation, Vol. 29, Iss. 11, 2009-11 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite

Ritonavir-boosted darunavir: a powerful option for treatment-experienced HIV-1-infected patients

By Menééndez-Arias Luis   Matamoros Tania   ÁÁlvarez Mar  

Future Virology, Vol. 3, Iss. 5, 2008-09 ,pp. : 423-434

Future Medicine

Access to resources Recommend Favorite

Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults

By Hentig Nils   Dauer Brenda   Haberl Annette   Klauke Stefan   Lutz Thomas   Staszewski Schlomo   Harder Sebastian  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 935-940

Springer Publishing Company

Access to resources Recommend Favorite